These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 10881052)

  • 21. Functional cartography of the ectodomain of the type I interferon receptor subunit ifnar1.
    Lamken P; Gavutis M; Peters I; Van der Heyden J; Uzé G; Piehler J
    J Mol Biol; 2005 Jul; 350(3):476-88. PubMed ID: 15946680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Creation of interferon-alpha8 mutants with amino acid substitutions against interferon-alpha receptor-2 binding sites using phage display system and evaluation of their biologic properties.
    Yamamoto K; Taniai M; Torigoe K; Yamamoto S; Arai N; Suemoto Y; Yoshida K; Okura T; Mori T; Fujioka N; Tanimoto T; Miyata M; Ariyasu H; Ushio C; Fujii M; Ariyasu T; Ikeda M; Ohta T; Kurimoto M; Fukuda S
    J Interferon Cytokine Res; 2009 Mar; 29(3):161-70. PubMed ID: 19196068
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The neutralization of type I IFN biologic actions by anti-IFNAR-2 monoclonal antibodies is not entirely due to inhibition of Jak-Stat tyrosine phosphorylation.
    Novick D; Nabioullin RR; Ragsdale W; McKenna S; Weiser W; Garone L; Burkins C; Kim SH; Rubinstein M; Tepper MA; Arulanandam AR
    J Interferon Cytokine Res; 2000 Nov; 20(11):971-82. PubMed ID: 11096454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The intracellular domain of the second chain of the interferon-gamma receptor is interchangeable between species.
    Muthukumaran G; Donnelly RJ; Ebensperger C; Mariano TM; Garotta G; Dembic Z; Poast J; Baron S; Pestka S
    J Interferon Cytokine Res; 1996 Dec; 16(12):1039-45. PubMed ID: 8974007
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Localization of a receptor nonapeptide with a possible role in the binding of the type I interferons.
    Eid P; Langer JA; Bailly G; Lejealle R; Guymarho J; Tovey MG
    Eur Cytokine Netw; 2000 Dec; 11(4):560-73. PubMed ID: 11125298
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression and signaling specificity of the IFNAR chain of the type I interferon receptor complex.
    Constantinescu SN; Croze E; Murti A; Wang C; Basu L; Hollander D; Russell-Harde D; Betts M; Garcia-Martinez V; Mullersman JE; Pfeffer LM
    Proc Natl Acad Sci U S A; 1995 Nov; 92(23):10487-91. PubMed ID: 7479825
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Soluble expression of chicken interferon-gamma and antiviral activity of purified expression product].
    Qi J; Du Y; Zhu X; Hu B; Sun S; Zhang X; Liu Y
    Wei Sheng Wu Xue Bao; 2009 Jan; 49(1):85-91. PubMed ID: 19388269
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased antiviral activity of microscale-purified HuIFN alpha 8 (human interferon alpha 8) over HuIFN alpha 2b in Hep-2 cells challenged with Mengo virus.
    García JC; Ariza AM; Lasa AM; González LJ; Perez VB
    Biotechnol Appl Biochem; 2007 Nov; 48(Pt 3):159-65. PubMed ID: 17523917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biophysical analysis of the interaction of human ifnar2 expressed in E. coli with IFNalpha2.
    Piehler J; Schreiber G
    J Mol Biol; 1999 May; 289(1):57-67. PubMed ID: 10339405
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression and purification of recombinant, glycosylated human interferon alpha 2b in murine myeloma NSo cells.
    Rossmann C; Sharp N; Allen G; Gewert D
    Protein Expr Purif; 1996 Jun; 7(4):335-42. PubMed ID: 8776749
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of a novel subunit of the type I interferon receptor localized to human chromosome 21.
    Colamonici OR; Domanski P
    J Biol Chem; 1993 May; 268(15):10895-9. PubMed ID: 8496154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In Vivo Conditions Enable IFNAR-Independent Type I Interferon Production by Peritoneal CD11b+ Cells upon Thogoto Virus Infection.
    Kochs G; Anzaghe M; Kronhart S; Wagner V; Gogesch P; Scheu S; Lienenklaus S; Waibler Z
    J Virol; 2016 Oct; 90(20):9330-7. PubMed ID: 27512061
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hemin inhibits the interferon-beta-induced antiviral state in established cell lines.
    Fiorucci G; Percario ZA; Coccia EM; Battistini A; Rossi GB; Romeo G; Affabris E
    J Interferon Cytokine Res; 1995 May; 15(5):395-402. PubMed ID: 7544231
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Construction, Expression, Purification and Antiviral Activity of Fused Interferon-BLA (IFN-BLA).].
    Ma WZ; Shen Q; Han W; Lu CY; Yang SL; Gong Y
    Yi Chuan; 2005 May; 27(3):451-6. PubMed ID: 15985413
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intrinsic ligand binding properties of the human and bovine alpha-interferon receptors.
    Lim JK; Xiong J; Carrasco N; Langer JA
    FEBS Lett; 1994 Aug; 350(2-3):281-6. PubMed ID: 8070579
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human IFN-alpha protein engineering: the amino acid residues at positions 86 and 90 are important for antiproliferative activity.
    Hu R; Bekisz J; Schmeisser H; McPhie P; Zoon K
    J Immunol; 2001 Aug; 167(3):1482-9. PubMed ID: 11466368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of a domain of a human type I interferon receptor protein involved in ligand binding.
    Eid P; Tovey MG
    J Interferon Cytokine Res; 1995 Mar; 15(3):205-11. PubMed ID: 7584665
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of residues of the IFNAR1 chain of the type I human interferon receptor critical for ligand binding and biological activity.
    Cajean-Feroldi C; Nosal F; Nardeux PC; Gallet X; Guymarho J; Baychelier F; Sempé P; Tovey MG; Escary JL; Eid P
    Biochemistry; 2004 Oct; 43(39):12498-512. PubMed ID: 15449939
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiproliferative effects of interferon-alphaCon1 on ovarian clear cell adenocarcinoma in vitro and in vivo.
    Takemoto Y; Yano H; Momosaki S; Ogasawara S; Nishida N; Kojiro S; Kamura T; Kojiro M
    Clin Cancer Res; 2004 Nov; 10(21):7418-26. PubMed ID: 15534119
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression, refolding, and characterization of GFE peptide-fused human interferon-alpha2a in Escherichia coli.
    Yan Z; Lu L; Shi J; Bao C; Han W; Wu Y; Zhang Y
    Appl Biochem Biotechnol; 2006 May; 133(2):149-62. PubMed ID: 16702607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.